The report "Neuroendocrine Tumors Therapeutics Market by Drug Class (Somatostatin Analogues,(Octreotide, Lanreotide, Pasireotide), Chemotherapeutics (Fluorouracil (5-FU), Doxorubicin (Adriamycin) or liposomal doxorubicin (Doxil), Streptozocin, Temozolomide (Temodar), Capecitabine (Xeloda), Dacarbazine (DTIC), Oxaliplatin (Eloxatin)), Targeted Therapeutics, (Sunitinib, Everolimus, Others)), By Indication (Lung NET, Others NET, Gastrointestinal NET, Pancreatic NET), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others)- Global Forecasts to 2030", is projected to reach USD 1.8 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period 2024-2030. The growth of the neuroendocrine tumors therapeutics market is majorly driven by the increasing prevalence of neuroendocrine carcinoma.
The neuroendocrine tumour treatment that is now being used is curative, taking into account both the symptoms and complications related to the aetiology of the disease. One crucial procedure that medical professionals use while treating neuroendocrine tumours is surgery. Surgery is no longer a realistic option due to the asymptomatic nature of the disease, which is addressed only after it has spread to other areas of the body.
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=15981
Competitive Dashboard:
The prominent key players operating in the global neuroendocrine tumors therapeutics market are Advanced Accelerator Applications (a subsidiary of Novartis AG), BioSynthema Inc., Bristol-Myers Squibb Company, Bionano Genomics, callistopharma, Exact Sciences Corporation, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Hutchison China MediTech Limited , Thermo Fisher Scientific Inc., Novartis AG, Regeneron Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., LUPIN, Pfizer Inc., Ipsen Pharma, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Illumina, Inc., GlaxoSmithKline plc, Viatris Inc.
Regional Overview:
The report also examines the current concerns and their Future Effects on the neuroendocrine tumors therapeutics market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the neuroendocrine tumors therapeutics market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
North America (U.S., Canada)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
A Few Points from the Table of Contents –
1. Executive Summary
2. Global Neuroendocrine Tumors Therapeutics Market Introduction
3. Global Neuroendocrine Tumors Therapeutics Market Dynamics
4. Global Neuroendocrine Tumors Therapeutics Market Analysis, 2019 - 2023 and Forecast 2024 – 2030
……………….
9. Global Neuroendocrine Tumors Therapeutics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10. North America Neuroendocrine Tumors Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11. Europe Neuroendocrine Tumors Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12. Asia Pacific (APAC) Neuroendocrine Tumors Therapeutics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13. Middle East and Africa (MEA) Neuroendocrine Tumors Therapeutics Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14. Latin America Neuroendocrine Tumors Therapeutics Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15. Competition Landscape
16. Research Methodology
17. Appendix and Abbreviations
Scope of The Report:
The neuroendocrine tumors therapeutics market research report includes historical data, trending features, and market growth estimates for the future.
The neuroendocrine tumors therapeutics market qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
The neuroendocrine tumors therapeutics market report helps to provide the best results for business enhancement and business growth.
The neuroendocrine tumors therapeutics market key players covered here to help them strengthen their place in the market.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747